PE20040067A1 - Nueva formulacion para la administracion parenteral de crobenetina - Google Patents
Nueva formulacion para la administracion parenteral de crobenetinaInfo
- Publication number
- PE20040067A1 PE20040067A1 PE2003000512A PE2003000512A PE20040067A1 PE 20040067 A1 PE20040067 A1 PE 20040067A1 PE 2003000512 A PE2003000512 A PE 2003000512A PE 2003000512 A PE2003000512 A PE 2003000512A PE 20040067 A1 PE20040067 A1 PE 20040067A1
- Authority
- PE
- Peru
- Prior art keywords
- crobenetine
- parenteral administration
- new formulation
- biii
- concentration
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 2
- ILVITZMPXQQPBD-OFAXGOBFSA-N crobenetine Chemical compound O([C@H](CN1[C@@H]2CC3=CC=CC=C3[C@@H](C2(C)C)CC1)C)CC1=CC=CC=C1 ILVITZMPXQQPBD-OFAXGOBFSA-N 0.000 title 1
- 229950005056 crobenetine Drugs 0.000 title 1
- 238000009472 formulation Methods 0.000 title 1
- 238000007911 parenteral administration Methods 0.000 title 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 abstract 3
- VCCBCXVFGHTDQN-UODBTFMRSA-N BIII-890CL Chemical compound O([C@H](CN1[C@@H]2CC3=C(O)C=CC=C3[C@](C2(C)C)(C)CC1)C)CC1=CC=CC=C1 VCCBCXVFGHTDQN-UODBTFMRSA-N 0.000 abstract 1
- 206010008190 Cerebrovascular accident Diseases 0.000 abstract 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 abstract 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 abstract 1
- 229930195725 Mannitol Natural products 0.000 abstract 1
- 208000006011 Stroke Diseases 0.000 abstract 1
- 102100025342 Voltage-dependent N-type calcium channel subunit alpha-1B Human genes 0.000 abstract 1
- 101710088658 Voltage-dependent N-type calcium channel subunit alpha-1B Proteins 0.000 abstract 1
- 239000008351 acetate buffer Substances 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- 208000026106 cerebrovascular disease Diseases 0.000 abstract 1
- 238000001990 intravenous administration Methods 0.000 abstract 1
- 235000010355 mannitol Nutrition 0.000 abstract 1
- 239000000594 mannitol Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Vascular Medicine (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Emergency Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10223784A DE10223784A1 (de) | 2002-05-29 | 2002-05-29 | Neue Formulierung zur parenteralen Applikation von Crobenetine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20040067A1 true PE20040067A1 (es) | 2004-03-30 |
Family
ID=29432394
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2003000512A PE20040067A1 (es) | 2002-05-29 | 2003-05-27 | Nueva formulacion para la administracion parenteral de crobenetina |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP1511487A1 (de) |
| JP (1) | JP2005531573A (de) |
| AR (1) | AR040135A1 (de) |
| AU (1) | AU2003240699A1 (de) |
| CA (1) | CA2487153A1 (de) |
| DE (1) | DE10223784A1 (de) |
| PE (1) | PE20040067A1 (de) |
| TW (1) | TW200406205A (de) |
| UY (1) | UY27824A1 (de) |
| WO (1) | WO2003099280A1 (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10223783A1 (de) * | 2002-05-29 | 2003-12-11 | Boehringer Ingelheim Pharma | Neue Formulierung zur parenteralen Applikation eines Na-Kanal-Blockers |
-
2002
- 2002-05-29 DE DE10223784A patent/DE10223784A1/de not_active Withdrawn
-
2003
- 2003-05-23 AU AU2003240699A patent/AU2003240699A1/en not_active Abandoned
- 2003-05-23 WO PCT/EP2003/005400 patent/WO2003099280A1/de not_active Ceased
- 2003-05-23 CA CA002487153A patent/CA2487153A1/en not_active Abandoned
- 2003-05-23 EP EP03730101A patent/EP1511487A1/de not_active Withdrawn
- 2003-05-23 JP JP2004506804A patent/JP2005531573A/ja active Pending
- 2003-05-27 TW TW092114284A patent/TW200406205A/zh unknown
- 2003-05-27 PE PE2003000512A patent/PE20040067A1/es not_active Application Discontinuation
- 2003-05-27 UY UY27824A patent/UY27824A1/es not_active Application Discontinuation
- 2003-05-28 AR ARP030101864A patent/AR040135A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE10223784A1 (de) | 2003-12-11 |
| WO2003099280A1 (de) | 2003-12-04 |
| AR040135A1 (es) | 2005-03-16 |
| EP1511487A1 (de) | 2005-03-09 |
| UY27824A1 (es) | 2003-12-31 |
| CA2487153A1 (en) | 2003-12-04 |
| AU2003240699A1 (en) | 2003-12-12 |
| TW200406205A (en) | 2004-05-01 |
| JP2005531573A (ja) | 2005-10-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20050066A1 (es) | Formulaciones farmaceuticas liquidas de palonosetron | |
| PE20030399A1 (es) | Formas de administracion de propiverina o sus sales farmaceuticamente aceptables con liberacion prolongada de la sustancia activa | |
| BG107347A (bg) | Висококонцентрирани стабилни разтвори на мелоксикам | |
| PE20030575A1 (es) | Soluciones de meloxicam estables y muy concentradas para la inyeccion sin aguja | |
| CY1114000T1 (el) | Σταθεροποιημενα διαλυματα τεριπαρατιδης | |
| GT199800113A (es) | Preparacion farmaceutica oral que comprende un compuesto de actividad antiulcerosa y procedimiento para su obtencion. | |
| BRPI0409185A (pt) | formulações veterinárias anti-helmìnticas tópicas | |
| AR029373A1 (es) | Metodo para el tratamiento de migranas, utilizando compuestos antagonistas selectivos de los receptores iglur5, uso de dichos compuestos antagonistas selectivos en la manufactura de medicamentos para el tratamiento de migranas y dichos compuestos antagonistas | |
| NO20062713L (no) | 2,6 bisheteroaryl-4-aminopyrimidiner som adenosin reseptor antagonister | |
| PE20010053A1 (es) | Formulacion de amoxicilina y clavulanato de potasio | |
| PE20050822A1 (es) | Derivados de florfenicol con mejor solubilidad en agua | |
| AR082049A1 (es) | Formulaciones liquidas de rupatadina fumarato | |
| PE20031044A1 (es) | Derivados de fenilimidazolidina y proceso de preparacion | |
| ES2224917T1 (es) | Composiciones farmaceuticas de agente fibrinolitico. | |
| ATE367165T1 (de) | Xanthangummi enthaltende reepithelialisierende pharmazeutische zubereitungen | |
| DK1401405T3 (da) | Orale, farmaceutiske sammensætninger med forbedret biotilgængelighed | |
| AR031649A1 (es) | Composicion farmaceutica de dronedarona para administracion parenteral | |
| PE20061437A1 (es) | Composicion en emulsion que comprende derivados de cicloalqueno, estable en rango acido | |
| AR016382A1 (es) | Uso de un derivado del acido bencil-indazol metoxialcanoico. | |
| ES2028917T3 (es) | Un procedimiento para preparar una composicion farmaceutica inyectable estable. | |
| BR0013283A (pt) | Agente farmacêutico que compreende um derivado de benzamida como ingrediente ativo | |
| PE20040067A1 (es) | Nueva formulacion para la administracion parenteral de crobenetina | |
| ES2197781A1 (es) | Composiciones farmaceuticas liquidas de base acuosa en forma de suspension para la administracion por via oral de ibuprofeno. | |
| PE20011320A1 (es) | Suspension esteroidal estabilizada | |
| PE20030092A1 (es) | Formulacion de una solucion de inhalacion con una sal de tiotropio |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |